Winnoz means “Winning Innovation Z”. Winnoz was founded in 2014 after the founder Dr. Hsiung received an investment from Israel because of his successful tech transfer record in Tel Aviv University. Dr. Hsiung aims to set up a company providing the winning innovations to its clients, and after clients search out all solutions, they would find that Winnoz is the solution Z, the best solution. This is the origin of “Winnoz”.
Winnoz is a biotech company focused on the Internet of Medical Things (IoMT). Our vision is to be the family health steward of every customer. With the IoMT platform from blood collection, detection and big data analysis, we enable more contribution for human health management for anyone, anywhere.
We believe that preventability is the key for a better health management as a family steward to make sure that healthcare resources could be accessible to everyone and everywhere.
We first launched the WinGene genetic testing service by offering risk report with genetic testing to better assist customers in managing health and well-being. In 2019, our patented technology –Haiim, a unique blood collection device, obtained Taiwan FDA Class I Medical Device and got CE certified in 2020.
Now, we collaborate with many worldwide distributors for global expansion and aim for US FDA cleared by 2021.
In the future we look to launch further products and services for health testing and risk assessment, extending our expertise into the worlds of diet consultations, lifestyle coaching and much more.
Eventually we hope to offer full PoCT with our devices, and will use all of our technology in unison to become the family health steward for every customer.
Always here for you.